<?xml version='1.0' encoding='ISO-8859-1'?>
<xml>
<title>Illinois General Assembly - Bill Status for HB 4233   </title>
<shortdesc>PRESCRIPTION DRUG ETHICAL MARK</shortdesc>
<sponsor>
<sponsorhead1>House Sponsors</sponsorhead1><sponsors>Rep. Jack D. Franks-Ralph C. Capparelli-Harry Osterman and Ron Stephens</sponsors>
</sponsor>
<lastaction>
<statusdate>1/11/2005</statusdate><chamber>House</chamber><action>Session Sine Die</action>
</lastaction>
<synopsis>
<synopsistitle></synopsistitle>
<reference>New Act</reference><aliasreference></aliasreference><SynopsisText>     Creates the Prescription Drug Ethical Marketing Act. Requires every manufacturer and labeler that sells prescription drugs in the State to disclose to the Director of Public Health the value, nature, and purpose of any gift, fee, payment, subsidy, or other economic benefit provided in connection with detailing or promotional or other marketing activities by the company, directly or through its pharmaceutical marketers, to any physician, hospital, nursing home, pharmacist, health benefit plan administrator, or any other person in Illinois authorized to prescribe or dispense prescription drugs. Requires the Director to report to the Governor and the General Assembly on the disclosures. Provides exceptions to the disclosures. Provides for injunctive relief and civil penalties for failure to disclose.</SynopsisText></synopsis>
<actions>
<statusdate>1/27/2004</statusdate><chamber>House</chamber><action>Filed with the Clerk by Rep. Jack D. Franks</action>
<statusdate>1/30/2004</statusdate><chamber>House</chamber><action>First Reading</action>
<statusdate>1/30/2004</statusdate><chamber>House</chamber><action>Referred to Rules Committee</action>
<statusdate>2/19/2004</statusdate><chamber>House</chamber><action>Assigned to State Government Administration Committee</action>
<statusdate>2/25/2004</statusdate><chamber>House</chamber><action>Do Pass / Short Debate State Government Administration Committee;  007-001-002</action>
<statusdate>2/25/2004</statusdate><chamber>House</chamber><action>Placed on Calendar 2nd Reading - Short Debate</action>
<statusdate>3/2/2004</statusdate><chamber>House</chamber><action>Second Reading - Short Debate</action>
<statusdate>3/2/2004</statusdate><chamber>House</chamber><action>Placed on Calendar Order of 3rd Reading - Short Debate</action>
<statusdate>3/23/2004</statusdate><chamber>House</chamber><action>Floor Motion Rep Parke moved to Place Bill on Standard Debate</action>
<statusdate>3/23/2004</statusdate><chamber>House</chamber><action>Motion Prevailed by Voice Vote</action>
<statusdate>3/23/2004</statusdate><chamber>House</chamber><action>Removed from Short Debate Status Rep. Terry R. Parke</action>
<statusdate>3/23/2004</statusdate><chamber>House</chamber><action>Calendar Order of 3rd Reading - Standard Debate</action>
<statusdate>3/23/2004</statusdate><chamber>House</chamber><action>Third Reading - Consideration Postponed</action>
<statusdate>3/23/2004</statusdate><chamber>House</chamber><action>Placed on Calendar - Consideration Postponed</action>
<statusdate>3/23/2004</statusdate><chamber>House</chamber><action>Added Co-Sponsor Rep. Ron Stephens</action>
<statusdate>3/24/2004</statusdate><chamber>House</chamber><action>Added Chief Co-Sponsor Rep. Harry Osterman</action>
<statusdate>3/26/2004</statusdate><chamber>House</chamber><action>Added Chief Co-Sponsor Rep. Ralph C. Capparelli</action>
<statusdate>4/2/2004</statusdate><chamber>House</chamber><action>Rule 19(a) / Re-referred to Rules Committee</action>
<statusdate>1/11/2005</statusdate><chamber>House</chamber><action>Session Sine Die</action>
</actions>
</xml>

